| Financier | Commitments |
|---|---|
| International Bank for Reconstruction and Development | 120.00 |
Panama COVID-19 Emergency Response
Abstract*
An outbreak of the coronavirus disease (COVID-19) caused by the 2019 novel coronavirus (SARS-CoV-2) has been spreading rapidly across the world since December 2019, following the diagnosis of the initial cases in Wuhan, Hubei Province, China. Since the beginning of March 2020, the number of cases outside China has grown exponentially and the crisis has reached global scale. On March 11, 2020, the World Health Organization (WHO) declared a global pandemic... Show More
Development Objective
To prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in the Republic of Panama.
Key Details
Project Details
P173881
Closed
Federica Secci , Gianluca Cafagna
Republic of Panama
May 4, 2020
(as of board presentation)
June 11, 2020
August 11, 2020
US$ 120.00 million
Ministry of Health
2020
US$ 120.00 million
N/A
Substantial
December 31, 2024
No
BANK APPROVED
April 25, 2024
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | 120.00 |
| IDA Commitment | N/A |
| IBRD + IDA Commitment | 120.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 120.00 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Apr 15, 2024 | IBRD-91500 | Int Charges | 2,585.76 |
| Apr 15, 2024 | IBRD-93770 | Int Charges | 48,018.34 |
| Apr 15, 2024 | IBRD-93770 | Int Charges | 2,062,208.80 |
| Apr 15, 2024 | IBRD-91500 | Int Charges | 354,044.06 |
| Apr 15, 2024 | IBRD-91500 | Int Charges | 240,447.95 |
| Apr 15, 2024 | IBRD-91500 | Loan Repay | 784,065.94 |
| Apr 15, 2024 | IBRD-91500 | Loan Repay | 465,934.06 |
| Jun 1, 2023 | IBRD-93770 | Fee Charges | 250,000.00 |
| Oct 15, 2023 | IBRD-93770 | Int Charges | 10,958.91 |
| Oct 15, 2023 | IBRD-91500 | Int Charges | 6,621.28 |
| Oct 15, 2023 | IBRD-91500 | Int Charges | 3,934.72 |
| Oct 15, 2023 | IBRD-91500 | Int Charges | 348,414.94 |
| Oct 15, 2023 | IBRD-91500 | Int Charges | 220,849.98 |
| Oct 15, 2023 | IBRD-91500 | Loan Repay | 784,065.94 |
| Dec 6, 2023 | IBRD-93770 | Loan Disb | 86,000,000.00 |
| Apr 15, 2023 | IBRD-91500 | Int Charges | 12,830.51 |
| Apr 15, 2023 | IBRD-91500 | Int Charges | 7,624.58 |
| Apr 15, 2023 | IBRD-91500 | Loan Repay | 784,065.94 |
| Apr 15, 2023 | IBRD-91500 | Int Charges | 300,393.22 |
| Apr 15, 2023 | IBRD-91500 | Int Charges | 178,509.78 |
| Oct 15, 2022 | IBRD-91500 | Int Charges | 163,034.97 |
| Oct 15, 2022 | IBRD-91500 | Int Charges | 96,884.11 |
| Oct 15, 2021 | IBRD-91500 | Loan Disb | 7,454,945.00 |
| Oct 15, 2021 | IBRD-91500 | Loan Disb | -7,454,945.00 |
| Apr 15, 2022 | IBRD-91500 | Int Charges | 919.11 |
| Apr 15, 2022 | IBRD-91500 | Int Charges | 2,062.87 |
| Apr 15, 2022 | IBRD-91500 | Int Charges | 46,932.46 |
| Apr 15, 2022 | IBRD-91500 | Int Charges | 27,889.80 |
| Sep 27, 2021 | IBRD-91500 | Loan Disb | 7,454,945.00 |
| Oct 15, 2020 | IBRD-91500 | Loan Disb | -12,545,055.00 |
| Oct 15, 2020 | IBRD-91500 | Loan Disb | 12,545,055.00 |
| Oct 15, 2021 | IBRD-91500 | Int Charges | 816.98 |
| Oct 15, 2021 | IBRD-91500 | Int Charges | 51,016.56 |
| Apr 15, 2021 | IBRD-91500 | Int Charges | 2,956.91 |
| Apr 15, 2021 | IBRD-91500 | Int Charges | 50,737.79 |
| Oct 6, 2020 | IBRD-91500 | Loan Disb | 12,495,055.00 |
| Aug 11, 2020 | IBRD-91500 | Loan Disb | 50,000.00 |
| Aug 11, 2020 | IBRD-91500 | Fee Charges | 50,000.00 |
| Jun 11, 2020 | IBRD-91500 | Loan Commitment | 20,000,000.00 |
| Mar 29, 2022 | IBRD-93770 | Loan Commitment | 100,000,000.00 |
| May 9, 2024 | IBRD-93770 | Loan Disb | 4,440,212.00 |
| Jun 11, 2024 | IBRD-93770 | Loan Disb | 572,278.70 |
| Apr 23, 2024 | IBRD-93770 | Loan Disb | 5,100,000.00 |
| Nov 27, 2023 | IBRD-93770 | Loan Disb | 138,179.31 |
| Apr 15, 2024 | IBRD-91500 | Int Charges | 4,079.33 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Financial Management | Satisfactory | 2024-06-18 |
| Monitoring and Evaluation | Satisfactory | 2024-06-18 |
| Overall Implementation Progress (IP) | Moderately Satisfactory | 2024-06-18 |
| Progress towards achievement of PDO | Moderately Satisfactory | 2024-06-18 |
| Procurement | Moderately Satisfactory | 2024-06-18 |
| Project Management | Moderately Satisfactory | 2024-06-18 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Laboratories with COVID-19 diagnostic equipment, test kits, and reagents Value 1.00 14.00 14.00 Date June 11, 2020 April 15, 2024 December 31, 2024 Comment Confirmed cases of COVID-19 reported and investigated per approved protocol in the country Value 0.00 80.00 70.00 Date June 11, 2020 April 15, 2024 December 31, 2024 Comment ICU and intermediate care units equipped pursuant to National COVID-19 protocol Value 0.00 13.00 9.00 Date June 11, 2020 April 15, 2024 December 31, 2024 Comment Population vaccinated, which is included in the priority population targets defined in national plan [by sex] Value 0.00 84.00 84.00 Date December 31, 2020 April 15, 2024 December 31, 2024 Comment Prioritized health institutions that implement waste management measures in accordance with the institution’s waste management plan Value 0.00 0.00 70.00 Date December 30, 2021 December 29, 2023 December 31, 2024 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Participating health institutions with personal protective equipment and infection control products and supplies Value 10.00 100.00 80.00 Date June 11, 2020 April 15, 2024 December 31, 2024 Comment Participating health institutions that comply with the Surface Cleaning and Disinfection Guide Value 10.00 100.00 80.00 Date June 11, 2020 April 15, 2024 December 31, 2024 Comment Share of modules for the care of patients with severe respiratory symptoms located in health institutions Value 0.00 100.00 80.00 Date June 11, 2020 April 15, 2024 December 31, 2024 Comment User satisfaction with the services received in the project health institutions Value 0.00 80.00 60.00 Date April 30, 2021 April 15, 2024 December 31, 2024 Comment Health institutions with an updated waste management plan Value 0.00 100.00 80.00 Date December 30, 2021 April 15, 2024 December 31, 2024 Comment Personnel of the prioritized health institutions receiving support on integrated waste management that have been trained in integrated management of waste Value 0.00 0.00 80.00 Date December 30, 2021 April 15, 2024 December 31, 2024 Comment Consultations for hypertension among patients in the Indigenous Comarcas conducted via telemedicine services [by sex] Value 0.00 0.00 100.00 Date December 30, 2021 April 15, 2024 December 31, 2024 Comment Public communication and advocacy campaigns supported by the project Value 0.00 0.00 3.00 Date December 30, 2021 April 15, 2024 December 31, 2024 Comment Patients who report being 'satisfied' or 'very satisfied' with their telemedicine consultation Value 70.00 70.00 80.00 Date December 30, 2021 April 15, 2024 December 31, 2024 Comment An electronic system exists to collect feedback on the implementation of the telemedicine program from program users, and MINSA hasconsidered the feedback in the expansion of the program Value No No Yes Date December 30, 2021 April 15, 2024 December 31, 2024 Comment Male patients benefiting from consultations for hypertension via telemedicine services Value 32.00 32.00 50.00 Date December 30, 2021 April 15, 2024 December 31, 2024 Comment